Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Laminar Medica Ltd

    Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    No items found

    Company Details

    Laminar Medica Ltd
    Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
    +44 (0)1442 828664
    Contact Laminar Medica Ltd
    Website

     Latest Content from PMHub 

    Streamlining European expansion for cell and gene therapies

    White Papers and Resources | September 16, 2025 | Uniphar

    Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell and gene therapies (CGTs). Europe...

    Current CGT landscape and future outlook  

    White Papers and Resources | September 16, 2025 | Uniphar

    What makes CGT unique  Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases. Personalized to the patient, CGT’s offer...

    Building for Success: Aligning Preclinical and Phase 1 Strategy with Commercial Goals 

    White Papers and Resources | September 16, 2025 | Uniphar

    This article concludes our three-part series on preparing cell and gene therapies (CGTs) for successful launch and long-term viability. The first article explored the unique scientific and logistical challenges of...

    Navigating the complexities of launch preparation for Cell and Gene Therapy

    White Papers and Resources | September 16, 2025 | Uniphar

    Cell and gene therapies (CGT) provide transformative treatment that can treat conditions that were previously considered untreatable. As described in the previous article in this series, most CGTs target patients...

    Virtual Practice, Real Results: The Power of Virtual Patient Simulation

    Press Releases | September 15, 2025 | Medscape Education

    Simulation has never been more vital in medicine than it is today. As increasing numbers of physicians turn to large language models for clinical answers1, the real differentiator isn’t just...

    A New Destination for Oncology Education

    Press Releases | September 15, 2025 | Medscape Education

    Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce...

    A Call to Action: Bridging the Adult Immunization Divide

    Press Releases | September 12, 2025 | Medscape Education

    Over the past few years, as new diseases have emerged or reemerged, a host of new vaccines have become available while many others are in the pipeline. For older adults,...

    ISPOR hosts expert webinar exploring the value of ECAs for regulatory and HTA evidence needs

    Press Releases | September 12, 2025 | Genesis Research Group

    On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...

    Streamline Clinical Trial Collaboration – Engaging Your Advisors Creatively

    Videos and Podcasts | September 11, 2025 | Impetus Digital

    Boost efficiency in clinical operations! Learn a creative way to enhance communication between teams at different sites and streamline the development of study protocols, support materials, and journal submissions.

    IPG Health expands Influencer ID marketing expertise into Europe

    Press Releases | September 11, 2025 | IPG Health

    Strategic rollout will scale US success into key European markets, strengthening the network’s leadership of social media strategy in the health/pharma sector